Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies

Arnaud Vincent, MC del Esandi, CJJ Avezaat, CJ Vecht, Peter Sillevis Smitt, DW Bekkum, D Valerio, PM (Peter) Hoogerbrugge, A Bout

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)442-451
Number of pages10
JournalNeurosurgery
Volume41
Issue number2
Publication statusPublished - 1998

Cite this